Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy |
journalArticle |
2015 |
Blanchard, P.; Bakkour, M.; De Crevoisier, R.; Levy, A.; Baumert, H.; Patard, J. J.; Wibault, P.; Fizazi, K.; Bossi, A. |
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead |
journalArticle |
2015 |
Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C. |
How individual participant data meta-analyses have influenced trial design, conduct, and analysis |
journalArticle |
2015 |
Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group |
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma |
journalArticle |
2015 |
Diouf, M.; Bonnetain, F.; Barbare, J. C.; Bouche, O.; Dahan, L.; Paoletti, X.; Filleron, T. |
Mortality analyses in the updated French cohort of uranium miners (1946-2007) |
journalArticle |
2015 |
Rage, E.; Caer-Lorho, S.; Drubay, D.; Ancelet, S.; Laroche, P.; Laurier, D. |
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study |
journalArticle |
2015 |
Jourdain, A.; Auperin, A.; Minard-Colin, V.; Aladjidi, N.; Zsiros, J.; Coze, C.; Gandemer, V.; Bertrand, Y.; Leverger, G.; Bergeron, C.; Michon, J.; Patte, C. |
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials |
journalArticle |
2015 |
Faron, M.; Pignon, J. P.; Malka, D.; Bourredjem, A.; Douillard, J. Y.; Adenis, A.; Elias, D.; Bouché, O.; Ducreux, M. |
Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians |
journalArticle |
2015 |
Billaux, M.; Borget, I.; Prognon, P.; Pineau, J.; Martelli, N. |
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours |
journalArticle |
2015 |
Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X. |
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer |
journalArticle |
2015 |
Lazar, V.; Rubin, E.; Depil, S.; Pawitan, Y.; Martini, J. F.; Gomez-Navarro, J.; Yver, A.; Kan, Z.; Dry, J. R.; Kehren, J.; Validire, P.; Rodon, J.; Vielh, P.; Ducreux, M.; Galbraith, S.; Lehnert, M.; Onn, A.; Berger, R.; Pierotti, M. A.; Porgador, A.; Pramesh, C. S.; Ye, D. W.; Carvalho, A. L.; Batist, G.; Le Chevalier, T.; Morice, P.; Besse, B.; Vassal, G.; Mortlock, A.; Hansson, J.; Berindan-Neagoe, I.; Dann, R.; Haspel, J.; Irimie, A.; Laderman, S.; Nechushtan, H.; Al Omari, A. S.; Haywood, T.; Bresson, C.; Soo, K. C.; Osman, I.; Mata, H.; Lee, J. J.; Jhaveri, K.; Meurice, G.; Palmer, G.; Lacroix, L.; Koscielny, S.; Eterovic, K. A.; Blay, J. Y.; Buller, R.; Eggermont, A.; Schilsky, R. L.; Mendelsohn, J.; Soria, J. C.; Rothenberg, M.; Scoazec, J. Y.; Hong, W. K.; Kurzrock, R. |
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer |
journalArticle |
2015 |
Nascimento, C.; Borget, I.; Al Ghuzlan, A.; Deandreis, D.; Hartl, D.; Lumbroso, J.; Berdelou, A.; Lepoutre-Lussey, C.; Mirghani, H.; Baudin, E.; Schlumberger, M.; Leboulleux, S. |
Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx |
journalArticle |
2015 |
Gorphe, P.; Blanchard, P.; Breuskin, I.; Temam, S.; Tao, Y.; Janot, F. |
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty |
journalArticle |
2015 |
Martelli, N.; Devaux, C.; van den Brink, H.; Pineau, J.; Prognon, P.; Borget, I. |
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial |
journalArticle |
2015 |
Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva |
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer |
journalArticle |
2015 |
Burdett, S.; Pignon, J. P.; Tierney, J.; Tribodet, H.; Stewart, L.; Le Pechoux, C.; Aupérin, A.; Le Chevalier, T.; Stephens, R. J.; Arriagada, R.; Higgins, J. P.; Johnson, D. H.; Van Meerbeeck, J.; Parmar, M. K.; Souhami, R. L.; Bergman, B.; Douillard, J. Y.; Dunant, A.; Endo, C.; Girling, D.; Kato, H.; Keller, S. M.; Kimura, H.; Knuuttila, A.; Kodama, K.; Komaki, R.; Kris, M. G.; Lad, T.; Mineo, T.; Piantadosi, S.; Rosell, R.; Scagliotti, G.; Seymour, L. K.; Shepherd, F. A.; Sylvester, R.; Tada, H.; Tanaka, F.; Torri, V.; Waller, D.; Liang, Y. |
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial |
journalArticle |
2015 |
Levy, A.; Azria, D.; Pignon, J. P.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Leclercq, J.; Juzyna, B.; Ezra, P.; Lemanski, C.; Deutsch, E. |
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours |
journalArticle |
2015 |
Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X. |
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor |
journalArticle |
2015 |
Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F. |
Cost Of Genome Analysis: The Sanger Sequencing Method |
journalArticle |
2015 |
Perrier, L.; Heinz, D.; Baffert, S.; Zou, Z.; Durand Zaleski, I.; Rouleau, E.; Wang, Q.; Haddad, V.; Bringuier, P.; Merlio, J.; Caumont, C.; Lacroix, L.; Marino, P.; Borget, I. |
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor |
journalArticle |
2015 |
Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F. |
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has |
journalArticle |
2015 |
Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I. |
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
Design and statistical principles of the SHIVA trial |
journalArticle |
2015 |
Paoletti, X.; Asselain, B.; Kamal, M.; Servant, N.; Huppe, P.; Bieche, I.; Le Tourneau, C. |
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma |
journalArticle |
2015 |
Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E. |
Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort |
journalArticle |
2015 |
Chougnet, C. N.; Borget, I.; Leboulleux, S.; de la Fouchardiere, C.; Bonichon, F.; Criniere, L.; Niccoli, P.; Bardet, S.; Schneegans, O.; Zanetta, S.; Schvartz, C.; Drui, D.; Chauffert, B.; Rohmer, V.; Schlumberger, M. |
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma |
journalArticle |
2015 |
Diouf, M.; Bonnetain, F.; Barbare, J. C.; Bouche, O.; Dahan, L.; Paoletti, X.; Filleron, T. |
How individual participant data meta-analyses have influenced trial design, conduct, and analysis |
journalArticle |
2015 |
Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group |
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France |
journalArticle |
2015 |
Scotte, F.; Martelli, N.; Vainchtock, A.; Borget, I. |
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review |
journalArticle |
2015 |
Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M. |
Precision medicine for metastatic breast cancer--limitations and solutions |
journalArticle |
2015 |
Arnedos, M.; Vicier, C.; Loi, S.; Lefebvre, C.; Michiels, S.; Bonnefoi, H.; Andre, F. |
Predictors of Study Attrition in a Randomized Controlled Trial Evaluating a Perinatal Home-Visiting Program with Mothers with Psychosocial Vulnerabilities |
journalArticle |
2015 |
Foulon, S.; Greacen, T.; Pasquet, B.; Dugravier, R.; Saias, T.; Guedeney, N.; Guedeney, A.; Tubach, F.; Group, Capedp Study |
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement |
journalArticle |
2015 |
Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development |
Efficacy of vaccination against HPV infection to prevent cervical cancer in France |
journalArticle |
2015 |
Ribassin-Majed, L.; Hill, C.; Lounes, R. |
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models |
journalArticle |
2015 |
Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P. |
[Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives] |
journalArticle |
2015 |
Blanchard, P.; Bourhis, J.; Lacas, B.; Le Teuff, G.; Michiels, S.; Pignon, J. P. |
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives |
journalArticle |
2015 |
Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J. |
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection |
journalArticle |
2015 |
Tsao, M. S.; Marguet, S.; Le Teuff, G.; Lantuejoul, S.; Shepherd, F. A.; Seymour, L.; Kratzke, R.; Graziano, S. L.; Popper, H. H.; Rosell, R.; Douillard, J. Y.; Le-Chevalier, T.; Pignon, J. P.; Soria, J. C.; Brambilla, E. M. |
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival |
journalArticle |
2015 |
dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G. |
Long-term follow-up of TaG1 non-muscle-invasive bladder cancer |
journalArticle |
2015 |
Olivier Bosset, P.; Neuzillet, Y.; Paoletti, X.; Molinie, V.; Botto, H.; Lebret, T. |